Brainomix
AI-Enabled Precision Medicine
AI-Enabled Precision Medicine
Brainomix is a UK-based biotechnology startup that focuses on AI Enabled Precision Medicine. Since its establishment as a spin-out from the University of Oxford in 2010, the company has been committed to creating AI-powered imaging biomarkers to enable precision medicine for better treatment decisions.
Their innovative AI-powered imaging biomarkers and software solutions have gained recognition through numerous awards, assisting physicians worldwide in making better, life-saving decisions. Their dedication to advancing the field of precision medicine has garnered the attention of investors, with the latest £400.00K grant investment from Innovate UK in 09 October 2023.
Brainomix's focus on leveraging AI to revolutionize medical treatment decisions presents an exciting opportunity for potential investors looking to support groundbreaking advancements in biotechnology and healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | €16.70M | 5 |
|
20 Mar 2025 |
| Grant | £400.00K | 1 |
|
09 Oct 2023 |
| Series B | £16.00M | 4 |
|
16 Dec 2021 |
| Venture Round | £7.00M | 4 |
|
03 Apr 2018 |
| Series B | £1.50M | 2 |
|
17 Oct 2016 |
We care about your data, and we'd love to use cookies make your experience better.
